Michigan State University researchers, with the help of a groundbreaking medical device, are starting a clinical trial in Africa they hope will provide relief for the hundreds of thousands of children who survive cerebral malaria but are left stricken …
Author: The Medical News
Bevacizumab equivalent to ranibizumab in treating wet AMD
In a landmark drug-comparison study, Cleveland Clinic researchers found that bevacizumab (Avastin) is equivalent to ranibizumab (Lucentis) in the treatment of wet age-related macular degeneration (AMD) through two years.
Best and worst paid doctors: Survey
More and more U.S. doctors are regretting their career choices. According to an annual survey of physician pay called Physician Compensation Survey from Medscape/WebMD this is in spite of the hefty amounts that they make each year. However the survey r…
IRIDEX launches non-invasive MicroPulse Laser Trabeculoplasty for glaucoma
IRIDEX Corporation today announced the launch of a new non-invasive, in-office glaucoma procedure based on its proprietary MicroPulse technology. The new glaucoma therapy, a tissue-sparing, repeatable therapy called MicroPulse Laser Trabeculoplasty (M…
MCW professor receives 2012 Founders Award at AMSSM meeting
Craig Young, MD, was awarded the 2012 Founders Award at the 21th Annual Meeting of the American Medical Society for Sports Medicine, in Atlanta on April 24, 2012. The award is not given annually, but is bestowed when AMSSM leadership determines that so…
University of Kentucky researchers make major breakthrough in GA
University of Kentucky researchers, led by Dr. Jayakrishna Ambati, have made a major breakthrough in the “dry” form of age-related macular degeneration known as geographic atrophy.
Amniotic membrane transplantation prevents blindness in patients with SJS
Transplanting tissue from newborn fetal membranes prevents blindness in patients with a devastating disease called Stevens-Johnson syndrome, a Loyola University Medical Center study has found.
Case study in the Journal of AAPOS highlights need for vigilance
It has been estimated that roughly 4% to 6% of child abuse victims present first to an ophthalmologist. In a case study in the April issue of the Journal of American Association of Pediatric Ophthalmology and Strabismus, doctors at the University of Wa…
Computational adaptive optics for real-time in-vivo applications
Real-time, 3-D microscopic tissue imaging could be a revolution for medical fields such as cancer diagnosis, minimally invasive surgery and ophthalmology. University of Illinois researchers have developed a technique to computationally correct for aber…
R-Tech Ueno completes RK-023 phase I study on hypotrichosis of the eyelashes
R-Tech Ueno is pleased to announce the completion of a phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes.
Novel technological treatment for Leber Hereditary Optic Neuropathy
A research team, led by John Guy, M.D., professor of ophthalmology at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, has pioneered a novel technological treatment for Leber Hereditary Optic Neuropathy (LHON), an inher…
Cosmetic contact lens on the rise among Malaysians
Malaysia’s beauty contact lens market is fast catching up with developed countries in the region such as Singapore, Taiwan and South Korea, which are all exhibiting similar upward trending in the sales of these beauty accessories. GfK retail tracking…
ACT announces dosing of third patient in dry AMD Phase I/II trial
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today the dosing of the third patient in its Phase I/II trial for dry age-related macular degeneration (dry AMD) using retinal pigment epithelial (RPE) cells deri…
Regenerative medicine research offers hope for the blind
The University College London researchers transplanted immature vision cells directly into the mouse retina. They noted that within weeks the cells began to integrate into the retina and the researchers, led by Prof Robin Ali in the university’s Inst…
ARVO to host presentation of results from two clinical trials on neovascular AMD
ARVO is pleased to host a presentation of the one-year results from the U.K.’s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials …
Caffeine increases eye’s ability to produce tears
Researchers at the University of Tokyo’s School of Medicine have shown for the first time that caffeine intake can significantly increase the eye’s ability to produce tears, a finding that could improve treatment of dry eye syndrome. This common eye co…
OptiMedica’s Catalys Precision Laser System receives CE mark approval
Global ophthalmic company OptiMedica Corp. has announced that its Catalys Precision Laser System has been CE mark approved for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.
Viewpoints: Santorum pushed Romney on health care; GOP’s ‘classic male mistake’; ACOs and the anti-trust challenge
The Pennsylvanian was also by far the most effective Republican critic of RomneyCare. When he stood on stage in a debate and took apart the Massachusetts health law as a prototype for ObamaCare, Mr. Romney realized he couldn’t coast to the nomination. …
Changes in corneal thickness occur in patients at early stages of FECD
A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs’ Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need f…
Monitoring necessary for early intervention in Fuchs’ Endothelial Corneal Dystrophy patients
A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs’ Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need f…